Where Opportunity Is Found - Research & Analysis on Medicis Pharmaceutical Corp and Akorn, Inc.

Wed Jun 13, 2012 9:00am EDT

* Reuters is not responsible for the content in this press release.

  HONG KONG, Jun 13 (Marketwire) -- 
This morning, www.MarketFoundations.com announced new reports
highlighting Medicis Pharmaceutical Corp (NYSE: MRX) and Akorn, Inc.
(NASDAQ: AKRX). Free research downloads are available at
www.MarketFoundations.com/index.php?coa=MRX&cob=AKRX.

    With markets in correction mode, investors are looking to quantify an
accurate model, weighing positives and negatives of the months ahead.
Upcoming negative pressures include China's slowdown, the European
recession, the end of the Fed's Operation Twist stimulus program,
continued geopolitical risks, election uncertainty, and potential 2013
budget bombshell of tax hikes and spending cuts. Meanwhile, positive
offsets are driven by central banks (particularly China) cutting rather
than hiking rates, deceleration in fuel and food prices, increase in
consumer sentiment and resulting retail sales, signs of improvement in
housing sales and new strength in auto production schedules.

    Despite the current situation, our team continues to identify high
momentum situations with growth potential -- there remains strong
opportunity within careful discretion.

    Market Foundations is releasing new coverage on Medicis Pharmaceutical
Corp for its current position within the healthcare industry. Medicis
Pharmaceutical Corporation (Medicis) together with its wholly owned
subsidiaries is an independent specialty pharmaceutical company engaged
in the development and marketing of products for the treatment of
dermatological and aesthetic conditions in the United States and Canada.
The full research report on Medicis Pharmaceutical Corp (NYSE: MRX) is
available here: www.MarketFoundations.com/index.php?coa=MRX.

    Market Foundations has released research on Akorn, Inc. for its changing
role within the healthcare industry. Akorn, Inc. manufactures and markets
diagnostic and therapeutic ophthalmic pharmaceuticals, as well as
hospital drugs and injectable pharmaceuticals. In addition, the Company
has marketed and distributed vaccines purchased from outside sources. The
Company operates in three segments: ophthalmic, hospital drugs &
injectables, and contract services. The full research report on Akorn,
Inc. (NASDAQ: AKRX) is available here:
www.MarketFoundations.com/index.php?cob=AKRX.

    About Market Foundations
 By providing members with financial information
services, we provide the foundation investors need to build investing
intelligence. The difference between consistently making good investments
or bad investments is nothing more than the right information at the
right time.

    

Contact:

Gemma Cunningham
Email: contact@MarketFoundations.com 
www.MarketFoundations.com 

Copyright 2012, Marketwire, All rights reserved.

-0-
Comments (0)
This discussion is now closed. We welcome comments on our articles for a limited period after their publication.